Overland Park, KSNCT07293260Now EnrollingIRB Ready

Cardiovascular Disease Clinical Trial in Overland Park, KS

Access cutting-edge cardiovascular disease treatment through this clinical trial at a research site in Overland Park. Study-provided care at no cost to qualified participants.

Sponsored by Amgen

Quick Self-Assessment

See if you qualify for this Overland Park location

Preparing your pre-screening questions…

Expert Care in Overland Park

Access cardiovascular disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cardiovascular disease treatment provided free

Apply for This Overland Park Location

Check if you qualify for this cardiovascular disease clinical trial in Overland Park, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Overland Park

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Overland Park site if eligible
  4. 4Begin participation

About This Cardiovascular Disease Study in Overland Park

The primary objective of this trial is to evaluate the effect of olpasiran, compared to placebo, on non-calcified plaque (NCP) volume as measured by Coronary Computed Tomography Angiography (CCTA).

Sponsor: Amgen

Who Can Participate

Inclusion Criteria

Age 35 to ≤ 80 years.
Lp(a) ≥ 200 nmol/L during screening.
Angiographic evidence of coronary artery disease in at least one major epicardial vessel on screening CCTA.
History of myocardial infarction (presumed type 1 event due to plaque rupture/erosion) and/or coronary revascularization by percutaneous coronary intervention.

Exclusion Criteria

History of coronary artery bypass graft (CABG).
Moderate to severe renal dysfunction.
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) \> 3 x upper limit of normal (ULN), or total bilirubin (TBL) \> 2 x ULN during screening.
History of hemorrhagic stroke.
History of major bleeding disorder.
Planned cardiac surgery or arterial revascularization.
Severe heart failure.
Current, recent, or planned lipoprotein apheresis.
Previously received ribonucleic acid therapy specifically targeting Lp(a).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Overland Park?

Yes, this clinical trial (NCT07293260) has an active research site in Overland Park, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cardiovascular Disease Treatment Options in Overland Park, KS

If you're searching for cardiovascular disease treatment options in Overland Park, KS, this clinical trial (NCT07293260) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Overland Park research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cardiovascular disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cardiovascular disease clinical trials near you to find additional studies recruiting in your area.

More Heart Disease Trials in Overland Park, KS

See all heart disease clinical trials recruiting in Overland Park — not just this study.

Browse Heart Disease Trials in Overland Park

Ready to Join in Overland Park?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Overland Park, KS